Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
In Japan, the company will accelerate expansion into the fruit and vegetable markets and introduce products from other companies. In Asia, it will implement restructuring measures for Nichino India Pvt. Ltd. In North America, it will deepen its presence in the fruit and vegetable markets and strengthen its direct-sales structure in Mexico. In Central and South America, it will increase the sales mix of internally developed products. In Europe, it will expand sales based on its direct-sales structure in the United Kingdom and Ireland. In its non-agrochemical chemicals business, the company will promote and expand sales of termite-control chemicals, expand sales of luliconazole, and pursue development in the Asia-Pacific region.
Settlement payment of ¥1,072 million, impairment loss of ¥85 million, and other items. Total extraordinary losses were ¥1,250 million.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → 2Q cumulative 48,800 / Full year 116,000（2Q cumulative 2.3% (year-on-year change) / Full year 3.7% (change from previous fiscal year)） |
| Operating profit | Not disclosed → 2Q cumulative 4,900 / Full year 11,500（2Q cumulative 4.5% (year-on-year change) / Full year 5.7% (year-on-year change)） |
| Ordinary income | Not disclosed → 2Q cumulative 5,200 / Full year 11,000（2Q cumulative 11.5% (year-on-year change) / Full year 4.5% (change from previous fiscal year)） |
| Profit attributable to owners of the parent | Not disclosed → 2Q cumulative 3,800 / Full year 7,400（2Q cumulative 12.7% (year-on-year change) / Full year 2.4% (change from previous fiscal year)） |
| Net income per share | Not disclosed → 2Q cumulative 48.53 / Full year 94.50 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Results for the fiscal year ended March 2026: net sales of ¥111,822 million, operating income of ¥10,878 million, ordinary income of ¥10,527 million, net income attributable to owners of the parent of ¥7,228 million, and earnings per share of ¥92.32 |
| Reason for the revision | In Japan, the company will accelerate expansion into the fruit and vegetable markets and introduce products from other companies. In Asia, it will implement restructuring measures for Nichino India Pvt. Ltd. In North America, it will deepen its presence in the fruit and vegetable markets and strengthen its direct-sales structure in Mexico. In Central and South America, it will increase the sales mix of internally developed products. In Europe, it will expand sales based on its direct-sales structure in the United Kingdom and Ireland. In its non-agrochemical chemicals business, the company will promote and expand sales of termite-control chemicals, expand sales of luliconazole, and pursue development in the Asia-Pacific region. |
| Details and amount of extraordinary loss | Settlement payment of ¥1,072 million, impairment loss of ¥85 million, and other items. Total extraordinary losses were ¥1,250 million. |
| Dividend forecast revision | The annual dividend forecast for the fiscal year ending March 2027 is ¥38.00, comprising an interim dividend of ¥14.00 and a year-end dividend of ¥24.00. Whether this represents a revision to the previous forecast is Not disclosed. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Results for the fiscal year ended March 2026 improved due to increased agrochemical sales, mainly in Japan, North America, and Europe, as well as growth in higher-margin sales to North America and Europe. Ordinary income also benefited from compensation income related to the use of agrochemical registration data held by a U.S. subsidiary and increased equity-method investment income due to strong results at a European affiliate. For the fiscal year ending March 2027, the company plans to develop the domestic fruit and vegetable markets and introduce products from other companies, while pursuing a recovery in overseas sales, strengthening its direct-sales structure, and expanding product sales.